Deadline for LOI Submission to program lead (arthur.dantas@cancer.ca): July 22, 2026 Deadline to submit full application to program lead: September 23, 2026 This pilot funding program by the Lundin Cancer Fund – Canadian Cancer Society Glioblastoma Research Program is part of the newly launched GBM Research Collaborative. This collaborative ecosystem will allow researchers to share data and protocols,… Read more »
Deadline for LOI Submission to program lead (arthur.dantas@cancer.ca): July 22, 2026 Deadline to submit full application to program lead: September 23, 2026 This pilot funding program by the Lundin Cancer Fund – Canadian Cancer Society Glioblastoma Research Program is part of the newly launched GBM Research Collaborative. This collaborative ecosystem will allow researchers to share data and protocols,… Read more »
The Canadian Cancer Society’s Research Training Awards – Master’s program aims to support growth and innovation in the next generation of diverse cancer researchers across Canada. This program was co-developed with guidance from CCS advisors, including Black and Indigenous community members, and is continuously reviewed to monitor and improve its impact. Recognizing that marginalized groups… Read more »
The Canadian Cancer Society’s Research Training Awards – Master’s program aims to support growth and innovation in the next generation of diverse cancer researchers across Canada. This program was co-developed with guidance from CCS advisors, including Black and Indigenous community members, and is continuously reviewed to monitor and improve its impact. Recognizing that marginalized groups… Read more »
The Canadian Cancer Society’s Research Training Awards program aims to support growth and innovation in the next generation of diverse cancer researchers across Canada. This program seeks to build inclusive capacity in cancer research, while fostering interdisciplinary learning, knowledge translation, mentorship and patient and community engagement opportunities. To address structural and systemic barriers to inclusion,… Read more »
The Canadian Cancer Society’s Research Training Awards program aims to support growth and innovation in the next generation of diverse cancer researchers across Canada. This program seeks to build inclusive capacity in cancer research, while fostering interdisciplinary learning, knowledge translation, mentorship and patient and community engagement opportunities. To address structural and systemic barriers to inclusion,… Read more »
The Cancer Research Society (CRS), with the Canadian Cancer Society (CCS) and the Terry Fox Research Institute (TFRI), are launching a new funding opportunity dedicated entirely to investigator-initiated oncology clinical trials in Canada. With partners – the Lotte & John Hecht Memorial Foundation, Génome Québec, Kindred Foundation and Childhood Cancer Canada – this program aims to enable… Read more »
The Cancer Research Society (CRS), with the Canadian Cancer Society (CCS) and the Terry Fox Research Institute (TFRI), are launching a new funding opportunity dedicated entirely to investigator-initiated oncology clinical trials in Canada. With partners – the Lotte & John Hecht Memorial Foundation, Génome Québec, Kindred Foundation and Childhood Cancer Canada – this program aims to enable… Read more »
The Canadian Cancer Society Inclusive Excellence Prize The Inclusive Excellence Prize will be given to an individual who has demonstrated commitment, leadership and (potential for) impact in the advancement of Canada’s cancer research ecosystem from an equity, diversity, inclusion and accessibility lens, both among those conducting the research and those benefiting from its outcomes. The… Read more »
CCS partnered with the Creative Destruction Lab (CDL) in 2022 to launch CDL Cancer, a unique program for early-stage companies commercializing cancer research results. Through the program, CCS and CDL will connect brilliant scientists who have game-changing ideas with business mentors who can help bring those ideas to life. This partnership is delivered as 4 full… Read more »
Abstracts due date (mandatory, not competitive): October 8th, 2025 Funding start: June 1st, 2026 CCS is excited to launch the third round of the CCS Challenge Grants program (CHA-26). The Challenge Grants program will support cancer research projects across the cancer continuum and across disciplines, with an ultimate goal of solving a problem (i.e. a “challenge”)… Read more »
Abstracts due date (mandatory, not competitive): October 8th, 2025 Funding start: June 1st, 2026 CCS is excited to launch the third round of the CCS Challenge Grants program (CHA-26). The Challenge Grants program will support cancer research projects across the cancer continuum and across disciplines, with an ultimate goal of solving a problem (i.e. a “challenge”)… Read more »
Rural and remote communities in Canada receive less funding for healthcare and have less health infrastructure. People living in these regions are also more likely to die from cancer. Getting screened for cancer before symptoms appear has the potential to detect cancer early, and save lives. However, in rural and remote communities, there are… Read more »
Nominations due date: June 25, 2025, 5 pm ET Note updated prize definition: The Inclusive Excellence Prize will be given to an individual who has demonstrated commitment, leadership and (potential for) impact in the advancement of Canada’s cancer research ecosystem from an equity, diversity, inclusion and accessibility lens, among both those conducting the research and those benefiting from… Read more »
Abstracts due date (mandatory, not competitive): June 25, 2025, 5 pm ET CCS is excited to launch the Emerging Scholar Research Grants program (ESRG-26). This opportunity aims at advancing promising early career investigators from across Canada with a focused commitment to undertaking cancer research. Through this program, early career investigators will develop their independent cancer… Read more »
Abstracts due date (mandatory, not competitive): June 25, 2025, 5 pm ET CCS is excited to launch the Emerging Scholar Research Grants program (ESRG-26). This opportunity aims at advancing promising early career investigators from across Canada with a focused commitment to undertaking cancer research. Through this program, early career investigators will develop their independent cancer… Read more »
Abstracts due date (mandatory, not competitive): June 25, 2025, 5 pm ET CCS is excited to launch the Emerging Scholar Research Grants program (ESRG-26). This opportunity aims at advancing promising early career investigators from across Canada with a focused commitment to undertaking cancer research. Through this program, early career investigators will develop their independent cancer… Read more »
The impetus for the RISE competition (Research Impact in Survivorship and Engagement) is for individuals with lived experience of ovarian cancer (either as a patient or caregiver), to define national priorities for ovarian cancer survivorship research and care. These priorities – and how a patient’s quality of life throughout and beyond treatment is defined in… Read more »
CCS is partnering with Cystic Fibrosis Canada to launch a grant competition that will focus on cystic fibrosis and cancer risk. This collaboration reflects that as people live longer with cystic fibrosis, they also face increased susceptibility to cancer risks that have not been extensively studied before. Seed Grants are valued at up to $50,000… Read more »
The intent of the CCS Breakthrough Team Grants model is to bring together passionate and talented teams of scientists, clinicians, patient partners, and knowledge users from across disciplines to work synergistically and ‘think big’ to address important gaps in cancer research that will be transformational for people affected by the disease. The primary scientific objectives… Read more »
The intent of the CCS Breakthrough Team Grants model is to bring together passionate and talented teams of scientists, clinicians, patient partners, and knowledge users from across disciplines to work synergistically and ‘think big’ to address important gaps in cancer research that will be transformational for people affected by the disease. The primary scientific objectives… Read more »
The Lotte & John Hecht Memorial Foundation in partnership with the Canadian Cancer Society are excited to announce a pre-launch of a new funding opportunity – “Disruptive Innovation Grants in Cancer Research”. These grants will provide a unique opportunity for researchers in cancer, or any other field of discipline, to test out their novel ideas… Read more »
The Lotte & John Hecht Memorial Foundation in partnership with the Canadian Cancer Society are excited to announce a pre-launch of a new funding opportunity – “Disruptive Innovation Grants in Cancer Research”. These grants will provide a unique opportunity for researchers in cancer, or any other field of discipline, to test out their novel ideas… Read more »
Over many decades Canada has invested in the collection of cancer data through registries, medical records and research studies. Despite continued investments and new initiatives, there have been growing concerns about the ability to link datasets and the comprehensiveness of linked datasets, challenges regarding timely access to data for reporting and further research, and the… Read more »
Over many decades Canada has invested in the collection of cancer data through registries, medical records and research studies. Despite continued investments and new initiatives, there have been growing concerns about the ability to link datasets and the comprehensiveness of linked datasets, challenges regarding timely access to data for reporting and further research, and the… Read more »
The Canadian Cancer Society and partners are excited to announce the upcoming launch of a new funding opportunity, the CCS Breakthrough Team Grants: Transforming Low Survival Cancers. These grants will bring together the sharpest minds and research talent from across Canada and beyond, combining scientific and clinical expertise, with lived experience in a collaborative interdisciplinary… Read more »
The Canadian Cancer Society and partners are excited to announce the upcoming launch of a new funding opportunity, the CCS Breakthrough Team Grants: Transforming Low Survival Cancers. These grants will bring together the sharpest minds and research talent from across Canada and beyond, combining scientific and clinical expertise, with lived experience in a collaborative interdisciplinary… Read more »
The Canadian Cancer Society (CCS), the Canadian Institutes of Health Research – Institute of Cancer Research (CIHR-ICR), the Canadian Institutes of Health Research-Institute of Indigenous Peoples’ Health (CIHR-IIPH), and partners have committed approximately $5M over one year to jointly fund up to 25 Proof-of-Concept Grants focused on interventions in Primary Cancer Prevention. The long-term objective… Read more »
The Canadian Cancer Society (CCS), the Canadian Institutes of Health Research – Institute of Cancer Research (CIHR-ICR), the Canadian Institutes of Health Research-Institute of Indigenous Peoples’ Health (CIHR-IIPH), and partners have committed approximately $5M over one year to jointly fund up to 25 Proof-of-Concept Grants focused on interventions in Primary Cancer Prevention. The long-term objective… Read more »
The Canadian Cancer Society (CCS), the Canadian Institutes of Health Research – Institute of Cancer Research (CIHR-ICR), the Canadian Institutes of Health Research-Institute of Indigenous Peoples’ Health (CIHR-IIPH), and partners have committed approximately $5M over one year to jointly fund up to 25 Proof-of-Concept Grants focused on interventions in Primary Cancer Prevention. The long-term objective… Read more »
The Canadian Cancer Society (CCS) is issuing a special Atlantic Canada call for operating grant applications focused on cancer research. Applications are encouraged from all areas of cancer research (e.g. biomedical, clinical, health services, and (psycho)social, cultural, environmental and population health research). Applications for up to $100,000 per year for 3 years will be… Read more »
Program Launch: Mid-July 2020 Registration due date: August 28, 2020 Full application due date: October 16, 2020 Results announcement: January 8, 2021 Anticipated funding start date: January 15, 2021 __________________________________________________________________________________ The Canadian Cancer Society (CCS), the Canadian Institutes of Health Research – Institute of Cancer Research (CIHR-ICR), and Brain Canada Foundation (BC or Brain Canada)… Read more »
The Impact Grant program supports significant progression in cancer research programs that are anywhere in the continuum from basic, high impact discovery to translational work of direct relevance to the clinic, to applied research. Impact Grants aim to accelerate and focus the knowledge gained from scientific findings, in the short- to medium-term, into outcomes that… Read more »
The Impact Grant program supports significant progression in cancer research programs that are anywhere in the continuum from basic, high impact discovery to translational work of direct relevance to the clinic, to applied research. Impact Grants aim to accelerate and focus the knowledge gained from scientific findings, in the short- to medium-term, into outcomes that… Read more »
Invitation must be received to submit full application. The Canadian Cancer Society (CCS) is excited to launch the CCS Emerging Scholar Award program, aimed at establishing and advancing promising early career scientists and clinician scientists from across Canada with a focused commitment to undertaking cancer research. Through the CCS Emerging Scholar Award program, early career… Read more »
The Canadian Cancer Society (CCS) is excited to launch the CCS Emerging Scholar Award program, aimed at establishing and advancing promising early career scientists and clinician scientists from across Canada with a focused commitment to undertaking cancer research. Through the CCS Emerging Scholar Award program, early career investigators will develop their cancer research programs in… Read more »
Innovation Grants support the highest quality creative problem solving in cancer research. The goal of the Innovation program is to support the development and testing of transformative, paradigm-shifting concepts and approaches to address problems in cancer research, enhance our understanding of cancer, and generate novel approaches to confront the challenges we face in defeating cancer…. Read more »
The Impact Grant program supports significant progression in cancer research programs that are anywhere in the continuum from basic, high impact discovery to translational work of direct relevance to the clinic and beyond. The goal of the CCS Research Impact Grant program is to provide a mechanism for scientists to adopt innovations and accelerate the… Read more »
